Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Cue Biopharma (CUE) over the last 4 years, with Q3 2025 value amounting to $190000.0.

  • Cue Biopharma's Non-Current Debt fell 8569.28% to $190000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $190000.0, marking a year-over-year decrease of 8569.28%. This contributed to the annual value of $4.2 million for FY2023, which is 4770.38% down from last year.
  • Cue Biopharma's Non-Current Debt amounted to $190000.0 in Q3 2025, which was down 8569.28% from $190000.0 recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Non-Current Debt registered a high of $9.9 million during Q2 2022, and its lowest value of $190000.0 during Q2 2025.
  • For the 4-year period, Cue Biopharma's Non-Current Debt averaged around $5.1 million, with its median value being $5.2 million (2023).
  • Per our database at Business Quant, Cue Biopharma's Non-Current Debt tumbled by 2823.24% in 2023 and then plummeted by 9168.85% in 2025.
  • Quarter analysis of 4 years shows Cue Biopharma's Non-Current Debt stood at $8.0 million in 2022, then crashed by 47.7% to $4.2 million in 2023, then plummeted by 68.4% to $1.3 million in 2024, then crashed by 85.69% to $190000.0 in 2025.
  • Its last three reported values are $190000.0 in Q3 2025, $190000.0 for Q2 2025, and $1.3 million during Q3 2024.